4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-128176
Director sold 16,500 shares at $28.73 ($474,045)
- Director acquired 16,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Incerti Carlo Director | 2024-11-18 | Option exercise | +16,500 | $8.69 | $143,385 | 16,500 | D |
| Incerti Carlo Director | 2024-11-18 | Sale | −16,500 | $28.73 | $474,045 | 0 | D |
| Derivatives | |||||||
| Incerti Carlo Director | 2024-11-18 | Option exercise · Stock option (right to buy) | −16,500 | 22,693 | D | ||
| Open-market sales · 16,500 sh · avg $28.73 · $474,045 | |||||||
Loading xslF345X05/ownership.xml…